Elastagen Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 5

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $261M

  • Investors
  • 1

Elastagen General Information

Description

Operator of a clinical-stage medical company intended to develop human protein tropoelastin-based products that facilitate skin rejuvenation, scar remodeling, and tissue repair. The company offers injectable synthetic human elastin products and chemically cross-linked tropoelastin for aesthetic applications, thereby enabling patients to maintain the skin's elasticity and supple properties.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • National Innovation Centre 4
  • Cornwallis Street, Eveleigh
  • Sydney, New South Wales 2015
  • Australia
Primary Industry
Drug Discovery
Acquirer
Vertical(s)
Corporate Office
  • National Innovation Centre 4
  • Cornwallis Street, Eveleigh
  • Sydney, New South Wales 2015
  • Australia

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Elastagen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 06-Apr-2018 $261M Completed Generating Revenue
7. Grant 11-Oct-2016 Completed Clinical Trials - General
6. Later Stage VC (Series B) 01-Jun-2016 Completed Clinical Trials - General
5. Grant 25-Mar-2015 Completed Clinical Trials - General
4. Grant 23-Jul-2013 Completed Clinical Trials - General
3. Early Stage VC (Series A) 01-Aug-2008 Completed Startup
2. Seed Round 01-Jan-2005 Completed Startup
1. University Spin-Out 01-Jan-2003 Completed Startup
To view Elastagen’s complete valuation and funding history, request access »

Elastagen Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a clinical-stage medical company intended to develop human protein tropoelastin-based products that facilita
Drug Discovery
Sydney, Australia
5 As of 2016

Madison, WI

Pessac, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Elastagen Competitors (21)

One of Elastagen’s 21 competitors is Regenerative Medical Solutions, a Venture Capital-Backed company based in Madison, WI.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Regenerative Medical Solutions Venture Capital-Backed Madison, WI
Treefrog Therapeutics Venture Capital-Backed Pessac, France
Alkermes Formerly VC-backed Dublin, Ireland
SinocellTech Formerly VC-backed Beijing, China
Precigen Formerly VC-backed Germantown, MD
You’re viewing 5 of 21 competitors. Get the full list »

Elastagen Patents

Elastagen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20190275087-A1 Expansion and differentiation of stem cells Inactive 01-Mar-2018
WO-2018081866-A1 Biosynthetic devices Inactive 04-Nov-2016
WO-2017035595-A1 Formation of bone Inactive 01-Sep-2015
JP-2020097601-A Method of extracting protein Inactive 24-Sep-2013
JP-2016536275-A Protein extraction method Active 24-Sep-2013 C07K1/145
To view Elastagen’s complete patent history, request access »

Elastagen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Elastagen Former Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Amorepacific Ventures Corporate Venture Capital Minority
Australian Federal Government Government
Brandon Capital Venture Capital Minority
Cell Innovation Partners Venture Capital Minority
Cicada Innovations Accelerator/Incubator Minority
You’re viewing 5 of 10 investors. Get the full list »

Elastagen FAQs

  • When was Elastagen founded?

    Elastagen was founded in 2003.

  • Where is Elastagen headquartered?

    Elastagen is headquartered in Sydney, Australia.

  • What is the size of Elastagen?

    Elastagen has 5 total employees.

  • What industry is Elastagen in?

    Elastagen’s primary industry is Drug Discovery.

  • Is Elastagen a private or public company?

    Elastagen is a Private company.

  • What is the current valuation of Elastagen?

    The current valuation of Elastagen is .

  • What is Elastagen’s current revenue?

    The current revenue for Elastagen is .

  • How much funding has Elastagen raised over time?

    Elastagen has raised $15.2M.

  • Who are Elastagen’s investors?

    Amorepacific Ventures, Australian Federal Government, Brandon Capital, Cell Innovation Partners, and Cicada Innovations are 5 of 10 investors who have invested in Elastagen.

  • Who are Elastagen’s competitors?

    Regenerative Medical Solutions, Treefrog Therapeutics, Alkermes, SinocellTech, and Precigen are some of the 21 competitors of Elastagen.

  • When was Elastagen acquired?

    Elastagen was acquired on 06-Apr-2018.

  • Who acquired Elastagen?

    Elastagen was acquired by Allergan.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process